chronic hives

Celldex reports positive study results in chronic hives
Investing.com
Wed, 09/25/24 - 10:18 pm
Celldex
chronic spontaneous urticaria
chronic hives
barzolvolimab
clinical trials
Dupixent succeeds in chronic hives study, giving Sanofi, Regeneron a chance to rebound
BioPharma Dive
Wed, 09/11/24 - 11:19 am
Dupixent
chronic hives
Sanofi
Regeneron
FDA
Novartis cues up filings for remibrutinib in chronic hives
Pharmaphorum
Fri, 05/31/24 - 10:47 am
Novartis
remibrutinib
chronic hives
clinical trials
Celldex laces up next to Big Pharma players as drug reduces severity of chronic hives
Fierce Biotech
Mon, 11/6/23 - 11:31 am
Celldex Therapeutics
clinical trials
monoclonal antibodies
barzolvolimab
chronic hives
Novartis prepares for FDA submission for its chronic hives treatment
Clinical Trials Arena
Wed, 08/9/23 - 10:15 am
Novartis
remibrutinib
chronic hives
FDA
Chronic hives: Four major clinical trials to watch in 2023
Clinical Trials Arena
Wed, 05/3/23 - 11:53 am
chronic hives
chronic urticaria
clinical trials
Sanofi
Regeneron
dupilumab
Amgen
tezepelumab
Allakos
lirentelimab
Celldex Therapeutics
barzolvolimab
Cost watchdogs back Novartis' Xolair for big new market in chronic hives
Fierce Pharma
Thu, 03/12/15 - 09:36 pm
Novartis
Xolair
chronic hives
UK
NICE